Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure
|
GENOCEA BIOSCIENCES, INC. (GNCA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/13/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
06/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/13/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/09/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/09/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/08/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/08/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
06/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/03/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
06/03/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,355 shares
@ $0.06, valued at
$81.3 |
|
06/03/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,578 shares
@ $0.06, valued at
$94.7 |
|
06/03/2022 |
4
| Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 4,023 shares
@ $0.06, valued at
$241.4 |
|
06/02/2022 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities: |
06/02/2022 |
4
| SUMER JACQUELYN L (CHIEF LEGAL & COMPLIANCE OFF) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 2,500 shares
@ $0.0601, valued at
$150.3 |
|
06/02/2022 |
4
| Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 117,244 shares
@ $0.0617, valued at
$7.2k
|
|
06/01/2022 |
4
| Siber George (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 20,425 shares
@ $0.0653, valued at
$1.3k
|
|
06/01/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/27/2022 |
SC 13D/A
| New Enterprise Associates 16, L.P. has filed a Schedule 13D for Genocea Biosciences, Inc. |
05/26/2022 |
4
| Walker Paul Edward (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Sonsini Peter W. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Makhzoumi Mohamad (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Chang Carmen (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 16,525 shares
@ $0.0881, valued at
$1.5k
|
|
05/26/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 24,407 shares
@ $0.0765, valued at
$1.9k
|
|
05/24/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
04/29/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
04/28/2022 |
8-K
| Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits &nbs... |
04/05/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,212 shares
@ $1.25, valued at
$1.5k
|
|
04/05/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 963 shares
@ $1.25, valued at
$1.2k
|
|
|
|
|